Baricitinib
Baricitinib . Tomar baricitinib puede reducir su capacidad para combatir infecciones, y puede aumentar el riesgo de contraer infecciones graves, incluyendo las infecciones graves por hongos, bacterias o virus, que se propagan en todo el cuerpo. Baricitinib is a jak1/2 inhibitor that was first approved for treating moderate to severe rheumatoid arthritis (ra) but that later showed considerable efficacy in the control of exaggerated inflammatory responses that occur in a wide range of diseases. Tz8i7lfs_ybybm from Olumiant is a prescription medicine called a janus kinase (jak) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis after treatment with 1 or more medicines called tumor necrosis factor (tnf) blockers have been used, and did not work well enough or could not be tolerated. Your doctors will provide more information about how well it works and how safe it is in your condition. Es posible que se necesite tratar estas infecciones en un hospital, y